Protagenic Therapeutics Stock Price Prediction
| PTIX Stock | USD 1.37 0.02 1.48% |
Oversold Vs Overbought
63
Oversold | Overbought |
Protagenic Therapeutics stock price prediction is an act of determining the future value of Protagenic Therapeutics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Protagenic Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Protagenic Therapeutics and does not consider all of the tangible or intangible factors available from Protagenic Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Protagenic Therapeutics, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Protagenic Therapeutics' stock price prediction:Wall Street Target Price 4 |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Protagenic Therapeutics based on different types of headlines from major news networks to social media. The Protagenic stock price prediction module provides an analysis of price elasticity to changes in media outlook on Protagenic Therapeutics over a specific investment horizon. Using Protagenic Therapeutics hype-based prediction, you can estimate the value of Protagenic Therapeutics from the perspective of Protagenic Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Protagenic Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Protagenic Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Protagenic because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Protagenic Therapeutics after-hype prediction price | USD 1.49 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Protagenic |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Protagenic Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Protagenic Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Protagenic Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Protagenic Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Protagenic Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Protagenic Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Protagenic Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Protagenic Therapeutics' historical news coverage. Protagenic Therapeutics' after-hype downside and upside margins for the prediction period are 0.07 and 8.30, respectively. We have considered Protagenic Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Protagenic Therapeutics is dangerous at this time. Analysis and calculation of next after-hype price of Protagenic Therapeutics is based on 3 months time horizon.
Protagenic Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Protagenic Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Protagenic Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Protagenic Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.88 | 6.81 | 0.12 | 0.23 | 6 Events / Month | 3 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.37 | 1.49 | 8.76 |
|
Protagenic Therapeutics Hype Timeline
Protagenic Therapeutics is at this time traded for 1.37. The entity has historical hype elasticity of 0.12, and average elasticity to hype of competition of 0.23. Protagenic is forecasted to increase in value after the next headline, with the price projected to jump to 1.49 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 8.76%, whereas the daily expected return is at this time at 0.88%. The volatility of related hype on Protagenic Therapeutics is about 2660.16%, with the expected price after the next announcement by competition of 1.60. The company has return on total asset (ROA) of (0.4578) % which means that it has lost $0.4578 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9448) %, meaning that it created substantial loss on money invested by shareholders. Protagenic Therapeutics' management efficiency ratios could be used to measure how well Protagenic Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.21 in 2024. Return On Capital Employed is likely to rise to -1.17 in 2024. At this time, Protagenic Therapeutics' Total Current Assets are fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 12 M in 2024, whereas Total Assets are likely to drop slightly above 4.1 M in 2024. Given the investment horizon of 90 days the next forecasted press release will be in about 6 days. Check out Protagenic Therapeutics Basic Forecasting Models to cross-verify your projections.Protagenic Therapeutics Related Hype Analysis
Having access to credible news sources related to Protagenic Therapeutics' direct competition is more important than ever and may enhance your ability to predict Protagenic Therapeutics' future price movements. Getting to know how Protagenic Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Protagenic Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PMVP | Pmv PharmaceuticalsInc | (0.01) | 4 per month | 0.00 | (0.08) | 6.67 | (8.38) | 21.67 | |
| PHVS | Pharvaris BV | 1.55 | 8 per month | 0.00 | (0.14) | 6.27 | (8.97) | 19.42 | |
| PEPG | PepGen | 0.04 | 10 per month | 5.46 | 0.13 | 17.58 | (9.88) | 67.46 | |
| MOLN | Molecular Partners AG | (0.28) | 4 per month | 0.00 | (0.10) | 4.90 | (6.52) | 23.10 | |
| ADAG | Adagene | (0.02) | 5 per month | 0.00 | (0.05) | 10.16 | (13.14) | 32.26 |
Protagenic Therapeutics Additional Predictive Modules
Most predictive techniques to examine Protagenic price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Protagenic using various technical indicators. When you analyze Protagenic charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Protagenic Therapeutics Predictive Indicators
The successful prediction of Protagenic Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Protagenic Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Protagenic Therapeutics based on analysis of Protagenic Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Protagenic Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Protagenic Therapeutics's related companies. | 2023 | 2024 (projected) | Payables Turnover | 5.2E-5 | 4.9E-5 | Days Of Inventory On Hand | 269.53 | 275.1 |
Story Coverage note for Protagenic Therapeutics
The number of cover stories for Protagenic Therapeutics depends on current market conditions and Protagenic Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Protagenic Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Protagenic Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Protagenic Therapeutics Short Properties
Protagenic Therapeutics' future price predictability will typically decrease when Protagenic Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Protagenic Therapeutics often depends not only on the future outlook of the potential Protagenic Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Protagenic Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 4.3 M | |
| Cash And Short Term Investments | 4.1 M | |
| Shares Float | 3.2 M |
Check out Protagenic Therapeutics Basic Forecasting Models to cross-verify your projections. For more information on how to buy Protagenic Stock please use our How to Invest in Protagenic Therapeutics guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Complementary Tools for Protagenic Stock analysis
When running Protagenic Therapeutics' price analysis, check to measure Protagenic Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagenic Therapeutics is operating at the current time. Most of Protagenic Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagenic Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagenic Therapeutics' price. Additionally, you may evaluate how the addition of Protagenic Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
Is Protagenic Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Protagenic Therapeutics. If investors know Protagenic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Protagenic Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.15) | Return On Assets (0.46) | Return On Equity (0.94) |
The market value of Protagenic Therapeutics is measured differently than its book value, which is the value of Protagenic that is recorded on the company's balance sheet. Investors also form their own opinion of Protagenic Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Protagenic Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Protagenic Therapeutics' market value can be influenced by many factors that don't directly affect Protagenic Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Protagenic Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Protagenic Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Protagenic Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.